Table: begin end state 1 28 signal peptide 29 35 non-cytoplasmic 36 55 transmembrane 56 87 cytoplasmic 88 111 transmembrane 112 116 non-cytoplasmic 117 139 transmembrane 140 159 cytoplasmic 160 183 transmembrane 184 190 non-cytoplasmic 191 209 transmembrane 210 220 cytoplasmic 221 240 transmembrane 241 254 non-cytoplasmic 255 276 transmembrane 277 284 cytoplasmic 285 305 transmembrane 306 324 non-cytoplasmic 325 345 transmembrane 346 365 cytoplasmic 366 391 transmembrane 392 464 non-cytoplasmic 465 485 transmembrane 486 508 cytoplasmic 509 529 transmembrane 530 541 non-cytoplasmic 542 566 transmembrane 567 572 cytoplasmic 573 593 transmembrane 594 641 non-cytoplasmic 642 664 transmembrane 665 688 cytoplasmic
Input: >AZOBR_RS18105 MPRILNHAPWLVLAVLGAFALGTVALARGETINALWLVVAAVCTYLVSYRYYSLFIATRV MRLDPARPTPAMRHNDGLDYVPTNQYVLFGHHFAAIAGAGPLVGPVLAAQMGYLPGMLWI LAGVVVAGAVQDFMILFVSMRRDGRSLGELIKAELGDIPGVIALFGTFMIMVIILAVLAL VVVKALTNSPWGFFTVAATVPIALFMGIYMRFLRPGRIGEISIIGFFLLIAAILLGGQVA QSETWAPVFTLTGVQITWILIGYGFVASVLPVWLLLAPRDYLSTFLKVGTIVMLALCILL VAPPMKMPSVTRFIDGTGPVWSGSLFPFLFITIACGAVSGFHALISSGTTPKMVENELHT RFIGYGGMLTESFVAVMALVAASCIEPGIYFAMNSPPALLGTTAESAAQVINNWGFVITP EMITQTAQDVGEVSILSRAGGAPTLAVGMAQIFSELFGGKGMMAFWYHFAILFEALFILT AVDAGTRAGRFMLQDLLGVFFKPLQRTASWAGNLIATGLCVAAWGYILYQGVVDPLGGIN TFWPLFGISNQMLAGIALILATVVLFRMKRERYAWVTMVPAAWLLICTLTAGVQKVFHSN PAIGFLAHAERFSTAANEGRLLAPATSMEQMRQVIFNDYLDAALASLFVLVVLAVLVFGV LSCLKALRSDRPTTREIPTGGATARAGD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server